サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1400594

コエンザイムQ10市場規模 - 用途別、調査報告書、国別展望、価格動向、成長展望、競合業界シェア、世界予測、2023年～2032年

Coenzyme Q10 Market Size - By Application (Pharmaceuticals, Dietary Supplements, Cosmetics), Research Report, Country Outlook, Price Trends, Growth Prospects, Competitive Industry Share & Global Forecast, 2023-2032
出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 160 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.46円
コエンザイムQ10市場規模 - 用途別、調査報告書、国別展望、価格動向、成長展望、競合業界シェア、世界予測、2023年～2032年
出版日: 2023年11月09日
発行: Global Market Insights Inc.
ページ情報: 英文 160 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

コエンザイムQ10の世界市場は、この分野における研究開発の急増により、2023年から2032年にかけて10.5％以上のCAGRを記録すると思われます。

健康とウェルネスへの注目が高まる中、心臓の健康、エネルギー生産、抗酸化特性におけるCoQ10の潜在的な利点を明らかにする研究が大きな関心を呼んでいます。

例えば、2023年11月、イランの研究チームが執筆し、Biochemistry Research International誌に掲載された「Involvement of Coenzyme Q10 in Various Neurodegenerative and Psychiatric Diseases（様々な神経変性疾患および精神疾患におけるコエンザイムQ10の関与）」と題する最近の総説では、体内や特定の食品に存在する内在性抗酸化物質であるコエンザイムQ10（CoQ10）が、フリードライヒ失調症やその他の神経疾患のような症状の治療に役立つ可能性が示唆されています。研究者たちは、CoQ10の抗酸化作用とエネルギー調整作用が、神経系を変性や衰えから守るのではないかと提案しています。

このような探求の高まりは需要を喚起し、産業界はCoQ10製剤をより広く応用できるように革新し、強化する必要に迫られています。科学的な努力によってCoQ10の多面的な利点が解明されるにつれて、市場の成長軌道は現代における健康ソリューションの改善の探求と一致しています。

医薬品分野のコエンザイムQ10市場規模は、2023年から2032年にかけて顕著なCAGRを記録すると思われます。製薬業界は、心血管問題、神経障害、がん治療への潜在的応用の治療における役割のためにCoQ10を高く評価しています。抗酸化特性と細胞エネルギー産生への関与により、CoQ10は医薬品製剤の強化や様々な治療法の補完に有望視されています。医薬品におけるこの需要の高まりは、CoQ10が健康増進のための医療介入を進める上で不可欠な要素として継続的に探求され利用されていることを反映しています。

アジア太平洋のコエンザイムQ10産業は、2023年から2032年にかけて顕著なCAGRを示すと思われます。予防ヘルスケアに対する意識の高まりとともに、栄養補助食品や化粧品におけるCoQ10の消費が急増しています。この動向は、抗酸化作用と心臓の健康への効果が指摘されていることに後押しされています。さらに、アジア太平洋地域の高齢化人口が、加齢に関連した健康上の懸念に対処する可能性を求めてCoQ10を求めています。

この需要の増加は、この地域のホリスティックな健康法への傾倒を反映しており、多様な産業にわたるCoQ10市場の成長を促進しています。例えば、2021年8月、田中実社長が率いる株式会社カネカ（本社：東京都港区）は、コエンザイムQ10の活性型変異体が一過性の疲労を緩和する有効性を示すと宣言しました。最近の機能性表示では、一時的なストレスの中で睡眠の質を高め、そのようなストレスを軽減し、口腔内の潤いを持続させる能力が支持されています。カネカユアヘルスケア株式会社（社長：長江昭二、本社：東京都港区）は、このような機能性表示食品の新商品「私の力TM」を発売しました。

目次

第1章 調査手法と調査範囲

第2章 エグゼクティブサマリー

第3章 世界のコエンザイムQ10産業洞察

  • 産業区分
  • COVID-19の世界経済への影響
  • エコシステム分析
    • ベンダー・マトリックス
    • 流通チャネル分析
      • 販売業者
      • サプライヤー
      • 受託製造
      • 技術プロバイダー
  • 原材料分析：COVID-19の供給への影響
    • COVID-19の供給への影響
  • 業界情勢、2018年～2032年
  • 技術展望
  • 規制状況
    • 欧州
  • 価格分析
      • 地域別の価格設定COVID-19の影響
      • コスト構造分析
  • 業界への影響要因
    • 促進要因
      • 北米：化粧品需要の増加
      • 欧州：糖尿病と心血管疾患の有病率の増加
      • アジア太平洋：医薬品市場の拡大による需要の増加
    • 業界の潜在的リスク＆課題
      • 最低投与量の要件
  • 技術革新と持続可能性
  • 2022年の成長可能性分析
    • 新たなビジネスモデル
      • 新製品の上市
      • コラボレーション
  • ポーター分析
  • 競合情勢、2022年
    • 企業シェア分析、2022年
    • 主要企業の概要
    • 戦略ダッシュボード
  • PESTEL分析
  • COVID-19によるコエンザイムQ10需要への影響、用途別
    • 栄養補助食品
    • 医薬品
    • 化粧品
    • その他

第4章 コエンザイムQ10の世界市場：用途別

  • 主な用途動向
  • 医薬品
  • 栄養補助食品
  • 化粧品
  • その他

第5章 コエンザイムQ10の世界市場：地域別

  • 主な地域動向
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • ロシア
    • ポーランド
  • アジア太平洋
    • 中国
    • インド
    • 日本
  • ラテンアメリカ（LATAM）
    • ブラジル
    • メキシコ
  • 中東・アフリカ（MEA）

第6章 企業プロファイル

  • Kaneka Corporation
  • DSM
  • SourceOne Global Partners, LLC
  • Healthy Origins
  • Vitamin Shoppe, Inc.
  • NBTY, Inc.
  • Pharmavite LLC
  • QUTEN Research Institute LLC
  • Tishcon Corp.
  • Country Life, LLC
  • Natural Organics
  • Jarrow Formulas
  • NOW Foods
  • Pharma Nord, Inc.
  • Doctor's Best
  • Xiamen Kingdomway Group
  • GNC Holdings, Inc.
  • Nordic Naturals, Inc.

第7章 潜在顧客

  • Merck & Co.
    • 事業概要
    • 財務データ
    • 製品情勢
  • Abbott Laboratories
    • 事業概要
    • 財務データ
    • 情勢
  • Sun Pharmaceutical Industries Limited
    • 事業概要
    • 財務データ
    • 情勢
  • Pfizer
    • 事業概要
    • 財務データ
    • 情勢
  • Sanofi
    • 事業概要
    • 財務データ
    • 製品情勢
  • Bristol Myers Squibb
    • 事業概要
    • 財務データ
    • 情勢
  • Novartis
    • 事業概要
    • 財務データ
    • 情勢
  • Johnson & Johnson
    • 事業概要
    • 財務データ
    • 情勢
  • GlaxoSmithKline
    • 事業概要
    • 財務データ
    • 情勢
  • Unilever
    • 事業概要
    • 財務データ
    • 情勢
  • Avon Products, Inc
    • 事業概要
    • 財務データ
    • 情勢
  • Beiersdorf
    • 事業概要
    • 財務データ
    • 情勢
  • Henkel AG & Co., KGaA
    • 事業概要
    • 財務データ
    • 情勢
  • Oriflame Holding AG
    • 事業概要
    • 財務データ
    • 情勢
  • The Estee Lauder Companies Inc.
    • 事業概要
    • 財務データ
    • 情勢
  • Yves Rocher
    • 事業概要
    • 財務データ
    • 情勢
  • Shiseido Company, Limited
    • 事業概要
    • 財務データ
    • 情勢
  • Bluebonnet Nutrition
    • 事業概要
    • 財務データ
    • 情勢
  • Barlean's
    • 事業概要
    • 財務データ
    • 情勢
  • Natural Factors
    • 事業概要
    • 財務データ
    • 商品概要
  • LifeExtension
    • 事業概要
    • 財務データ
    • 情勢
図表

Data Tables

  • TABLE 1 Global coenzyme Q10 industry 3600 synopsis, 2023 - 2032
  • TABLE 2 Global coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 3 Global coenzyme Q10 market volume, by region, 2018 - 2032, (Tons)
  • TABLE 4 Global coenzyme Q10 market revenue, by region, 2018 - 2032, (USD Million)
  • TABLE 5 Global coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 6 Global coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 7 Vendor matrix
  • TABLE 8 CoQ10 distribution channel analysis
  • TABLE 9 Industry impact forces
  • TABLE 10 Top players overview
  • TABLE 11 Global coenzyme Q10 market from pharmaceutical application, 2018 - 2032, (Tons) (USD Million)
  • TABLE 12 Global coenzyme Q10 market volume from pharmaceutical application, by region, 2018 - 2032, (Tons)
  • TABLE 13 Global coenzyme Q10 market revenue from pharmaceutical application, by region, 2018 - 2032, (USD Million)
  • TABLE 14 Global coenzyme Q10 market from dietary supplements application, 2018 - 2032, (Tons) (USD Million)
  • TABLE 15 Global coenzyme Q10 market volume from dietary supplements application, by region, 2018 - 2032, (Tons)
  • TABLE 16 Global coenzyme Q10 market revenue from dietary supplements application, by region, 2018 - 2032, (USD Million)
  • TABLE 17 Global coenzyme Q10 market from cosmetics application, 2018 - 2032, (Tons) (USD Million)
  • TABLE 18 Global coenzyme Q10 market volume from cosmetics application, by region, 2018 - 2032, (Tons)
  • TABLE 19 Global coenzyme Q10 market revenue from cosmetics application, by region, 2018 - 2032, (USD Million)
  • TABLE 20 Global coenzyme Q10 market from other application, 2018 - 2032, (Tons) (USD Million)
  • TABLE 21 Global coenzyme Q10 market volume from other application, by region, 2018 - 2032, (Tons)
  • TABLE 22 Global coenzyme Q10 market revenue from other application, by region, 2018 - 2032, (USD Million)
  • TABLE 23 North America coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 24 North America coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 25 North America coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 26 U.S. coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 27 U.S. coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 28 U.S. coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 29 Canada coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 30 Canada coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 31 Canada coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 32 Europe coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 33 Europe coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 34 Europe coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 35 Germany coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 36 Germany coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 37 Germany coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 38 UK coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 39 UK coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 40 UK coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 41 France coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 42 France coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 43 France coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 44 Italy coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 45 Italy coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 46 Italy coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 47 Russia coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 48 Russia coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 49 Russia coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 50 Poland coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 51 Poland coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 52 Poland coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 53 Asia Pacific coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 54 Asia Pacific coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 55 Asia Pacific coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 56 China coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 57 China coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 58 China coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 59 India coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 60 India coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 61 India coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 62 Japan coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 63 Japan coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 64 Japan coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 65 LATAM coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 66 LATAM coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 67 LATAM coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 68 Brazil coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 69 Brazil coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 70 Brazil coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 71 Mexico coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 72 Mexico coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 73 Mexico coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 74 MEA coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 75 MEA coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 76 MEA coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)

Charts & Figures

  • FIG. 1 Global heart conditions & statistics, 2019, (% share)
  • FIG. 2 Global cosmetic market share by category, 2019, (% share)
  • FIG. 3 Europe cosmetic market by country, 2019, (USD billion)
  • FIG. 4 Industry segmentation
  • FIG. 5 Industry ecosystem analysis
  • FIG. 6 Global CoQ10 market estimates and forecast, 2018 - 2032 (Tons) (USD Million)
  • FIG. 7 Coenzyme Q10 technology landscape
  • FIG. 8 Lactobacilli price trends (USD/kilo)
  • FIG. 9 North America cosmetics market, 2018, (USD Million)
  • FIG. 10 Europe diabetes data, 2019, (% share)
  • FIG. 11 Europe attributable factors risk factors for CVD, 2020, (% share)
  • FIG. 12 Asia Pacific pharmaceutical market, 2017-2031, (USD Billion)
  • FIG. 13 Growth potential analysis, 2022
  • FIG. 14 Porter's analysis
  • FIG. 15 Company market share analysis, 2022
  • FIG. 16 PESTEL analysis
  • FIG. 17 SWOT Analysis, Kaneka Corporation
  • FIG. 18 SWOT Analysis, DSM
  • FIG. 19 SWOT Analysis, SourceOne Global Partners
  • FIG. 20 SWOT Analysis, Healthy Origins
  • FIG. 21 SWOT Analysis, Vitamin Shoppe, Inc
  • FIG. 22 SWOT Analysis, Nature's Bounty Co
  • FIG. 23 SWOT Analysis, Pharmavite LLC
  • FIG. 24 SWOT Analysis, Quten Research Institute
  • FIG. 25 SWOT Analysis, Tishcon Corp
  • FIG. 26 SWOT Analysis, Country Life, LLC
  • FIG. 27 SWOT Analysis, Natural Organics
  • FIG. 28 SWOT Analysis, Jarrow Formulas
  • FIG. 29 SWOT Analysis, NOW Foods
  • FIG. 30 SWOT Analysis, Pharma Nord
  • FIG. 31 SWOT Analysis, Doctor's Best, Inc
  • FIG. 32 SWOT Analysis, Xiamen Kingdomway Group
  • FIG. 33 SWOT Analysis, GNC Holdings, Inc
  • FIG. 34 SWOT Analysis, Nordic Naturals, Inc
目次
Product Code: 741

Global Coenzyme Q10 Market will witness over 10.5% CAGR between 2023 and 2032 due to burgeoning research and development in the field. With increased focus on health and wellness, studies revealing CoQ10's potential benefits in heart health, energy production, and antioxidant properties have sparked immense interest.

For instance, in November 2023, A recent review article titled "Involvement of Coenzyme Q10 in Various Neurodegenerative and Psychiatric Diseases," penned by a team of Iranian researchers and published in Biochemistry Research International, suggested that Coenzyme Q10 (CoQ10), an intrinsic antioxidant present in the body and certain foods, could potentially aid in treating conditions like Friedreich's ataxia and other neurological ailments. The researchers propose that CoQ10's antioxidative and energy-regulating properties might safeguard the neurological system from degeneration and decline.

This surge in exploration fuels demand, compelling industries to innovate and enhance CoQ10 formulations for wider applications. As scientific endeavors unravel its multifaceted advantages, the market growth trajectory aligns with the quest for improved health solutions in modern times.

The overall Coenzyme Q10 Market share is classified based on application and region.

Coenzyme Q10 market size from the pharmaceuticals segment will register a noteworthy CAGR from 2023 to 2032. Pharmaceutical industries value CoQ10 for its role in treating cardiovascular issues, neurological disorders, and potential applications in cancer treatment. With its antioxidant properties and involvement in cellular energy production, CoQ10 holds promise in enhancing drug formulations and supplementing various therapies. This escalating demand within pharmaceuticals reflects the continuous exploration and utilization of CoQ10 as a vital component in advancing medical interventions for improved health outcomes.

Asia Pacific coenzyme Q10 industry will showcase a commendable CAGR from 2023 to 2032. With rising awareness of preventive healthcare, there is a surge in CoQ10 consumption in dietary supplements and cosmetics. This trend is propelled by its antioxidant properties and purported benefits in heart health. Moreover, Asia Pacific's aging population seeks CoQ10 for its potential in addressing age-related health concerns.

This increasing demand reflects the region's inclination toward holistic health practices, driving the CoQ10 market growth across diverse industries. For instance, in August 2021, Kaneka Corporation, led by President Minoru Tanaka and headquartered in Minato-ku, Tokyo, declared that the active variant of Coenzyme Q10 demonstrates efficacy in alleviating transient fatigue. Recent functional claims endorse its ability to enhance sleep quality amidst temporary stress, reduce such stress, and aid in sustaining oral moisture. Consequently, Kaneka Your Health Care Co., Ltd., helmed by President Shoji Nagae and also based in Minato-ku, Tokyo, introduced a novel product line named "Watashi no ChikaraTM," featuring these functional benefits.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definitions
  • 1.2 Base estimates & working
    • 1.2.1 Forecast calculations
  • 1.3 Data Sources
    • 1.3.1 Primary
    • 1.3.2 Secondary
      • 1.3.2.1 Paid Sources
      • 1.3.2.2 Public Sources

Chapter 2 Executive Summary

  • 2.1 Global coenzyme Q10 industry 360 degree synopsis, 2023 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Regional trends
    • 2.1.3 Application trend

Chapter 3 Global coenzyme Q10 Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Impact of COVID-19 on world economy
  • 3.3 Industry ecosystem analysis
    • 3.3.1 Vendor matrix
    • 3.3.2 Distribution channel analysis
      • 3.3.2.1 Distributor
      • 3.3.2.2 Suppliers
      • 3.3.2.3 Contract Manufacturing
      • 3.3.2.4 Technology providers
  • 3.4 Raw material analysis: Covid-19 impact on supply
    • 3.4.1 Covid-19 impact on supply
  • 3.5 Industry landscape, 2018 - 2032
  • 3.6 Technology landscape
  • 3.7 Regulatory landscape
    • 3.7.1 Europe
  • 3.8 Pricing analysis
      • 3.8.1.1 Regional pricing: COVID-19 impact
      • 3.8.1.2 Cost structure analysis
  • 3.9 Industry impact forces
    • 3.9.1 Growth drivers
      • 3.9.1.1 North America: Growing demand for cosmetics product
      • 3.9.1.2 Europe: Increasing prevalence of diabetes and cardiovascular diseases
      • 3.9.1.3 Asia Pacific: Pharmaceutical market expansion leading to rising demand
    • 3.9.2 Industry pitfalls & challenges
      • 3.9.2.1 Minimum dosage requirement
  • 3.10 Innovation & sustainability
  • 3.11 Growth potential analysis, 2022
    • 3.11.1 Emerging business model
      • 3.11.1.1 New Product Launch
      • 3.11.1.2 Collaboration
  • 3.12 Porter's analysis
    • 3.12.1 Bargaining power of suppliers
    • 3.12.2 Bargaining power of buyers
    • 3.12.3 Threat of new entrants
    • 3.12.4 Threat of substitutes
  • 3.13 Competitive landscape, 2022
    • 3.13.1 Company market share analysis, 2022
    • 3.13.2 Top players overview
    • 3.13.3 Strategy dashboard
  • 3.14 PESTEL analysis
  • 3.15 COVID-19 impact on Coenzyme Q10 demand, by application
    • 3.15.1 Dietary Supplements
    • 3.15.2 Pharmaceuticals
    • 3.15.3 Cosmetics
    • 3.15.4 Others

Chapter 4 Global Coenzyme Q 10 Market, By Application

  • 4.1 Key application trends
  • 4.2 Pharmaceuticals
    • 4.2.1 Global coenzyme Q10 market from pharmaceutical application, 2018 - 2032, (Tons) (USD Million)
    • 4.2.2 Global coenzyme Q10 market from pharmaceutical application, by region, 2018 - 2032, (Tons) (USD Million)
  • 4.3 Dietary Supplements
    • 4.3.1 Global coenzyme Q10 market from dietary supplements application, 2018 - 2032, (Tons) (USD Million)
    • 4.3.2 Global coenzyme Q10 market from dietary supplements application, by region, 2018 - 2032, (Tons) (USD Million)
  • 4.4 Cosmetics
    • 4.4.1 Global coenzyme Q10 market from cosmetics application, 2018 - 2032, (Tons) (USD Million)
    • 4.4.2 Global coenzyme Q10 market from cosmetics application, by region, 2018 - 2032, (Tons) (USD Million)
  • 4.5 Others
    • 4.5.1 Global coenzyme Q10 market from other application, 2018 - 2032, (Tons) (USD Million)
    • 4.5.2 Global coenzyme Q10 market from other application, by region, 2018 - 2032, (Tons) (USD Million)

Chapter 5 Global Coenzyme Q 10 Market, By Region

  • 5.1 Key regional trends
  • 5.2 North America
    • 5.2.1 North America coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
    • 5.2.2 North America coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.2.3 U.S.
      • 5.2.3.1 U.S. coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.2.3.2 U.S. coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.2.4 Canada
      • 5.2.4.1 Canada coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.2.4.2 Canada coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
  • 5.3 Europe
    • 5.3.1 Europe coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
    • 5.3.2 Europe coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.3.3 Germany
      • 5.3.3.1 Germany coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.3.3.2 Germany coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.3.4 UK
      • 5.3.4.1 UK coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.3.4.2 UK coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.3.5 France
      • 5.3.5.1 France coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.3.5.2 France coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.3.6 Italy
      • 5.3.6.1 Italy coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.3.6.2 Italy coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.3.7 Russia
      • 5.3.7.1 Russia coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.3.7.2 Russia coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.3.8 Poland
      • 5.3.8.1 Poland coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.3.8.2 Poland coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
    • 5.4.2 Asia Pacific coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.4.3 China
      • 5.4.3.1 China coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.4.3.2 China coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.4.4 India
      • 5.4.4.1 India coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.4.4.2 India coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.4.5 Japan
      • 5.4.5.1 Japan coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.4.5.2 Japan coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
  • 5.5 Latin America (LATAM)
    • 5.5.1 LATAM coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
    • 5.5.2 LATAM coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.5.3 Brazil
      • 5.5.3.1 Brazil coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.5.3.2 Brazil coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.5.4 Mexico
      • 5.5.4.1 Mexico coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.5.4.2 Mexico coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
  • 5.6 Middle East & Africa (MEA)
    • 5.6.1 MEA coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
    • 5.6.2 MEA coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)

Chapter 6 Company Profiles

  • 6.1 Kaneka Corporation
    • 6.1.1 Business Overview
    • 6.1.2 Financial Data
    • 6.1.3 Product Landscape
    • 6.1.4 SWOT Analysis
  • 6.2 DSM
    • 6.2.1 Business Overview
    • 6.2.2 Financial Data
    • 6.2.3 Product Landscape
    • 6.2.4 SWOT Analysis
  • 6.3 SourceOne Global Partners, LLC
    • 6.3.1 Business Overview
    • 6.3.2 Financial Data
    • 6.3.3 Product Landscape
    • 6.3.4 SWOT Analysis
  • 6.4 Healthy Origins
    • 6.4.1 Business Overview
    • 6.4.2 Financial Data
    • 6.4.3 Product Landscape
    • 6.4.4 SWOT Analysis
  • 6.5 Vitamin Shoppe, Inc.
    • 6.5.1 Business Overview
    • 6.5.2 Financial Data
    • 6.5.3 Product Landscape
    • 6.5.4 SWOT Analysis
  • 6.6 NBTY, Inc.
    • 6.6.1 Business Overview
    • 6.6.2 Financial Data
    • 6.6.3 Product Landscape
    • 6.6.4 SWOT Analysis
  • 6.7 Pharmavite LLC
    • 6.7.1 Business Overview
    • 6.7.2 Financial Data
    • 6.7.3 Product Landscape
    • 6.7.4 SWOT Analysis
  • 6.8 QUTEN Research Institute LLC
    • 6.8.1 Business Overview
    • 6.8.2 Financial Data
    • 6.8.3 Product Landscape
    • 6.8.4 SWOT Analysis
  • 6.9 Tishcon Corp.
    • 6.9.1 Business Overview
    • 6.9.2 Financial Data
    • 6.9.3 Product Landscape
    • 6.9.4 SWOT Analysis
  • 6.10 Country Life, LLC
    • 6.10.1 Business Overview
    • 6.10.2 Financial Data
    • 6.10.3 Product Landscape
    • 6.10.4 SWOT Analysis
  • 6.11 Natural Organics
    • 6.11.1 Business Overview
    • 6.11.2 Financial Data
    • 6.11.3 Product Landscape
    • 6.11.4 SWOT Analysis
    • 6.11.5 Strategic Outlook
  • 6.12 Jarrow Formulas
    • 6.12.1 Business Overview
    • 6.12.2 Financial Data
    • 6.12.3 Product Landscape
    • 6.12.4 SWOT Analysis
  • 6.13 NOW Foods
    • 6.13.1 Business Overview
    • 6.13.2 Financial Data
    • 6.13.3 Product Landscape
    • 6.13.4 SWOT Analysis
  • 6.14 Pharma Nord, Inc.
    • 6.14.1 Business Overview
    • 6.14.2 Financial Data
    • 6.14.3 Product Landscape
    • 6.14.4 SWOT Analysis
  • 6.15 Doctor's Best
    • 6.15.1 Business Overview
    • 6.15.2 Financial Data
    • 6.15.3 Product Landscape
    • 6.15.4 SWOT Analysis
    • 6.15.5 Strategic Outlook
  • 6.16 Xiamen Kingdomway Group
    • 6.16.1 Business Overview
    • 6.16.2 Financial Data
    • 6.16.3 Product Landscape
    • 6.16.4 SWOT Analysis
  • 6.17 GNC Holdings, Inc.
    • 6.17.1 Business Overview
    • 6.17.2 Financial Data
    • 6.17.3 Product Landscape
    • 6.17.4 SWOT Analysis
  • 6.18 Nordic Naturals, Inc.
    • 6.18.1 Business Overview
    • 6.18.2 Financial Data
    • 6.18.3 Product Landscape
    • 6.18.4 SWOT Analysis

Chapter 7 Potential Customers

  • 7.1 Merck & Co.
    • 7.1.1 Business Overview
    • 7.1.2 Financial Data
    • 7.1.3 Product Landscape
  • 7.2 Abbott Laboratories
    • 7.2.1 Business Overview
    • 7.2.2 Financial Data
    • 7.2.3 Product Landscape
  • 7.3 Sun Pharmaceutical Industries Limited
    • 7.3.1 Business Overview
    • 7.3.2 Financial Data
    • 7.3.3 Product Landscape
  • 7.4 Pfizer
    • 7.4.1 Business Overview
    • 7.4.2 Financial Data
    • 7.4.3 Product Landscape
  • 7.5 Sanofi
    • 7.5.1 Business Overview
    • 7.5.2 Financial Data
    • 7.5.3 Product Landscape
  • 7.6 Bristol Myers Squibb
    • 7.6.1 Business Overview
    • 7.6.2 Financial Data
    • 7.6.3 Product Landscape
  • 7.7 Novartis
    • 7.7.1 Business Overview
    • 7.7.2 Financial Data
    • 7.7.3 Product Landscape
  • 7.8 Johnson & Johnson
    • 7.8.1 Business Overview
    • 7.8.2 Financial Data
    • 7.8.3 Product Landscape
  • 7.9 GlaxoSmithKline
    • 7.9.1 Business Overview
    • 7.9.2 Financial Data
    • 7.9.3 Product Landscape
  • 7.10 Unilever
    • 7.10.1 Business Overview
    • 7.10.2 Financial Data
    • 7.10.3 Product Landscape
  • 7.11 Avon Products, Inc
    • 7.11.1 Business Overview
    • 7.11.2 Financial Data
    • 7.11.3 Product Landscape
  • 7.12 Beiersdorf
    • 7.12.1 Business Overview
    • 7.12.2 Financial Data
    • 7.12.3 Product Landscape
  • 7.13 Henkel AG & Co., KGaA
    • 7.13.1 Business Overview
    • 7.13.2 Financial Data
    • 7.13.3 Product Landscape
  • 7.14 Oriflame Holding AG
    • 7.14.1 Business Overview
    • 7.14.2 Financial Data
    • 7.14.3 Product Landscape
  • 7.15 The Estee Lauder Companies Inc.
    • 7.15.1 Business Overview
    • 7.15.2 Financial Data
    • 7.15.3 Product Landscape
  • 7.16 Yves Rocher
    • 7.16.1 Business Overview
    • 7.16.2 Financial Data
    • 7.16.3 Product Landscape
  • 7.17 Shiseido Company, Limited
    • 7.17.1 Business Overview
    • 7.17.2 Financial Data
    • 7.17.3 Product Landscape
  • 7.18 Bluebonnet Nutrition
    • 7.18.1 Business Overview
    • 7.18.2 Financial Data
    • 7.18.3 Product Landscape
  • 7.19 Barlean's
    • 7.19.1 Business Overview
    • 7.19.2 Financial Data
    • 7.19.3 Product Landscape
  • 7.20 Natural Factors
    • 7.20.1 Business Overview
    • 7.20.2 Financial Data
    • 7.20.3 Product Landscape
  • 7.21 LifeExtension
    • 7.21.1 Business Overview
    • 7.21.2 Financial Data
    • 7.21.3 Product Landscape